Study on IGF Levels and Breast Cancer Risk
Author Information
Author(s): Allen N E, Roddam A W, Allen D S, Fentiman I S, dos Santos Silva I, Peto J, Holly J M P, Key T J
Primary Institution: Cancer Research UK Epidemiology Unit, University of Oxford
Hypothesis
Are high levels of serum IGF-I and low levels of IGFBP-3 associated with an increased risk of breast cancer in premenopausal women?
Conclusion
The study suggests that premenopausal women with high IGF-I and low IGFBP-3 levels may have an increased risk of developing breast cancer.
Supporting Evidence
- High levels of IGF-I were associated with increased breast cancer risk in premenopausal women.
- Low levels of IGFBP-3 were linked to higher breast cancer risk.
- No significant associations were found for postmenopausal women.
Takeaway
This study looked at blood samples from women to see if certain proteins related to growth hormones could predict breast cancer risk. They found that higher levels of one protein and lower levels of another might mean a higher chance of getting breast cancer for younger women.
Methodology
A nested case-control study within a cohort of women from Guernsey, comparing serum levels of IGF-I, IGF-II, and IGFBP-3 between breast cancer cases and matched controls.
Potential Biases
Potential bias due to the exclusion of women using exogenous hormones and the reliance on self-reported data for reproductive history.
Limitations
The study had a small sample size for postmenopausal women and relied on a single blood sample for hormone measurements.
Participant Demographics
117 breast cancer cases (70 premenopausal, 47 postmenopausal) and 350 matched controls.
Statistical Information
P-Value
0.21
Confidence Interval
0.74–3.95
Statistical Significance
p=0.21
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website